World-Class Research Centre
for Personalized Medicine
2 Akkuratova street, St. Petersburg 197341
Head of Laboratory — Tatyana Karonova, MD, DSc, Associate Professor.
To search for clinical, laboratory, molecular and genetic predictors of development, severe course, outcomes and varying degrees of effectiveness of therapy for the new coronavirus infection (COVID-19).
A unified database is being created to include patients who had a new coronavirus disease caused by SARS-CoV-2 and were hospitalized to the infectious diseases hospital of Almazov Centre in the period from 2020 to 2021.
A collection of pathological samples has been obtained from COVID-19 patients for a detailed study of damage to certain organs and systems in severe cases of coronavirus disease.
Two clinical trials were initiated and completed to investigate the effects of vitamin D deficiency on the pathogenesis and course of COVID-19 and the possibility of using cholecalciferol to prevent SARS-CoV-2 infection in medical professionals and reduce the severity and improve prognosis in patients with acute COVID-19.
A complete examination was initiated for patients who have had COVID-19 in the past at various times in the post-COVID period.
Karonova T. L., Chernikova A. T., Golovatyuk K. A., Bykova E. S., Grant W. B., Kalinina O. V., Grineva E. N., Shlyakhto E. V. Vitamin D Intake May Reduce SARS-CoV-2 Infection Morbidity in Health Care Workers. Nutrients 2022, 14, 505. https://doi.org/10.3390/nu14030505
Grant W. B., Al Anouti F., Boucher B. J., Dursun E., Gezen-Ak D., Jude E. B., Karonova T., Pludowski P. A Narrative Review of the Evidence for Variations in Serum 25-Hydroxyvitamin D Concentration Thresholds for Optimal Health. Nutrients 2022, 14, 639. https://doi.org/10.3390/nu14030639
Tatyana Karonova, Head of Laboratory